Author: Fujita, T.F.
Paper Title Page
TUA2 Present Status and Future Prospect of Heavy Ion Radiotherapy 49
  • A. Kitagawa, T.F. Fujita, M. Muramatsu
    QST-NIRS, Chiba, Japan
  Heavy Ion Radiotherapy is one of important applications of an ECRIS. When the authors reported the status of heavy ion radiotherapy in the ECRIS 2012, only five facilities carried out the treatment worldwide. At present, ten facilities are under operation and eight are under commissioning or construction. All of them utilize ECRISs for the production of carbon ions, mainly. Heavy ion radiotherapy exponentially awakens worldwide interest. There are many construction plans in various countries. Heavy ion radiotherapy has been approved to cover by the National Health Insurance in Japan since 2016. In April 2018, fees for treatment in Japan are revised to 1,600, 000 Yen for 'prostate tumor' and 2,375, 000 Yen for 'bone and soft tissue tumor' and 'head and neck tumor', respectively. The expectation of widespread use has accelerated sharply. On the other hand, the cost reduction for a facility has been urged too. We will summarize the present status and will speculate upon the future of heavy ion radiotherapy and related ECRIS's technology.  
slides icon Slides TUA2 [2.197 MB]  
DOI • reference for this paper ※  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)